Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
An individual randomised efficacy trial of autologous blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in leprosy in Nepal: the TABLE trial protocol.
Napit IB, Shrestha D, Bishop J, Choudhury S, Dulal S, Gill P, Gkini E, Gwyther H, Hagge DA, Neupane K, Sartori J, Slinn G, Watson SI, Lilford R. Napit IB, et al. Among authors: neupane k. Trials. 2021 Jul 15;22(1):453. doi: 10.1186/s13063-021-05392-5. Trials. 2021. PMID: 34266456 Free PMC article.
Autologous blood products: Leucocyte and Platelets Rich Fibrin (L-PRF) and Platelets Rich Plasma (PRP) gel to promote cutaneous ulcer healing - a systematic review.
Napit IB, Shrestha D, Neupane K, Adhikari A, Dhital R, Koirala R, Gopali L, Ilozumba O, Gill P, Watson SI, Choudhury S, Lilford RJ. Napit IB, et al. Among authors: neupane k. BMJ Open. 2023 Dec 12;13(12):e073209. doi: 10.1136/bmjopen-2023-073209. BMJ Open. 2023. PMID: 38086583 Free PMC article.
A randomised Trial of Autologous Blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in LEprosy: The TABLE trial.
Napit IB, Shrestha D, Choudhury S, Gkini E, Ilozumba O, Gill P, Bishop J, Neupane K, Adhikari A, Sartori J, Watson SI, Lilford R. Napit IB, et al. Among authors: neupane k. PLoS Negl Trop Dis. 2024 May 2;18(5):e0012088. doi: 10.1371/journal.pntd.0012088. eCollection 2024 May. PLoS Negl Trop Dis. 2024. PMID: 38696527 Free PMC article. Clinical Trial.
Disulfiram Reduces Atherosclerosis and Enhances Efferocytosis, Autophagy, and Atheroprotective Gut Microbiota in Hyperlipidemic Mice.
Traughber CA, Timinski K, Prince A, Bhandari N, Neupane K, Khan MR, Opoku E, Opoku E, Brubaker G, Shin J, Hong J, Kanuri B, Ertugral EG, Nagareddy PR, Kothapalli CR, Cherepanova O, Smith JD, Gulshan K. Traughber CA, et al. Among authors: neupane k. J Am Heart Assoc. 2024 Apr 16;13(8):e033881. doi: 10.1161/JAHA.123.033881. Epub 2024 Apr 2. J Am Heart Assoc. 2024. PMID: 38563369 Free article.
Disulfiram reduces atherosclerosis and enhances efferocytosis, autophagy, and atheroprotective gut microbiota in hyperlipidemic mice.
Traughber CA, Timinski K, Prince A, Bhandari N, Neupane K, Khan MR, Opoku E, Opoku E, Brubaker G, Nageshwar K, Ertugral EG, Naggareddy P, Kothapalli CR, Smith JD, Gulshan K. Traughber CA, et al. Among authors: neupane k. bioRxiv [Preprint]. 2023 Oct 19:2023.10.17.562757. doi: 10.1101/2023.10.17.562757. bioRxiv. 2023. PMID: 37905037 Free PMC article. Updated. Preprint.
143 results